PET of Adoptively Transferred Chimeric Antigen Receptor T Cells with (89)Zr-Oxine

Chimeric antigen receptor (CAR) T cell therapy is a promising clinical approach for reducing tumor progression and prolonging patient survival. However, improvements in both the safety and the potency of CAR T cell therapy demand quantitative imaging techniques to determine the distribution of cells...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Nucl Med
Glavni autori: Weist, Michael R., Starr, Renate, Aguilar, Brenda, Chea, Junie, Miles, Joshua K., Poku, Erasmus, Gerdts, Ethan, Yang, Xin, Priceman, Saul J., Forman, Stephen J., Colcher, David, Brown, Christine E., Shively, John E.
Format: Artigo
Jezik:Inglês
Izdano: Society of Nuclear Medicine 2018
Teme:
Oncology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6167529/
https://ncbi.nlm.nih.gov/pubmed/29728514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.117.206714
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items